Humacyte Stock Price on September 30, 2023
| HUMA Stock | USD 4.43 0.15 3.50% |
If you're considering investing in Humacyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of Humacyte stands at 4.43, as last reported on the 27th of November, with the highest price reaching 4.49 and the lowest price hitting 4.12 during the day. Humacyte holds Efficiency (Sharpe) Ratio of -0.0762, which attests that the entity had a -0.0762% return per unit of risk over the last 3 months. Humacyte exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Humacyte's Market Risk Adjusted Performance of (0.34), risk adjusted performance of (0.08), and Standard Deviation of 5.05 to validate the risk estimate we provide.
At present, Humacyte's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 7.1 M, whereas Total Stockholder Equity is forecasted to decline to about 7.6 M. . At present, Humacyte's Price Book Value Ratio is projected to increase based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 96.95. Humacyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Humacyte |
Sharpe Ratio = -0.0762
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HUMA |
Estimated Market Risk
| 5.05 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Humacyte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Humacyte by adding Humacyte to a well-diversified portfolio.
Price Book 30.2811 | Enterprise Value Ebitda 4.3389 | Price Sales 153.9075 | Shares Float 91.3 M | Wall Street Target Price 13 |
Related Headline
Theseus Pharmaceuticals Headline on 24th of July 2023
Theseus Pharmaceuticals Inc is lower by 3.62 percent Monday ... by news.google.com
Theseus Pharmaceuticals Inc is lower by 3.62 percent Monday In Premarket Trading InvestorsObserver
Humacyte Valuation on September 30, 2023
It is possible to determine the worth of Humacyte on a given historical date. On September 30, 2023 Humacyte was worth 2.92 at the beginning of the trading date compared to the closed value of 2.93. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Humacyte stock. Still, in general, we apply an absolute valuation method to find Humacyte's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Humacyte where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Humacyte's related companies.
| Open | High | Low | Close | Volume | |
| 2.95 | 3.02 | 2.87 | 2.92 | 273,800 | |
09/29/2023 | 2.92 | 2.95 | 2.86 | 2.93 | 276,100 |
| 3.04 | 3.04 | 2.78 | 2.82 | 381,100 |
| Backtest Humacyte | | | Humacyte History | | | Humacyte Valuation | Previous | Next |
Humacyte Trading Date Momentum on September 30, 2023
| On October 02 2023 Humacyte was traded for 2.82 at the closing time. The top price for the day was 3.04 and the lowest listed price was 2.78 . The trading volume for the day was 381.1 K. The trading history from October 2, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.75% . The trading delta at closing time against the current closing price is 2.39% . |
Humacyte Fundamentals Correlations and Trends
By evaluating Humacyte's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Humacyte's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Humacyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Humacyte Stock history
Humacyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Humacyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Humacyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Humacyte stock prices may prove useful in developing a viable investing in Humacyte
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 103.4 M | 61.4 M | |
| Net Loss | -13.8 M | -14.4 M |
Humacyte Quarterly Net Working Capital |
|
Humacyte Stock Technical Analysis
Humacyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Humacyte Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Humacyte cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Humacyte November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Humacyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Humacyte shares will generate the highest return on investment. By undertsting and applying Humacyte stock market strength indicators, traders can identify Humacyte entry and exit signals to maximize returns
Humacyte Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Humacyte's price direction in advance. Along with the technical and fundamental analysis of Humacyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Humacyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (0.35) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Humacyte Stock analysis
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |